Are dabrafenib and trametinib included in medical insurance?

Yes, both dabrafenib and trametinib have been successfully included in my country’s medical insurance. This initiative greatly reduces the financial burden on patients and allows more patients to obtain these two effective treatments. Dabrafenib and trametinib are important targeted therapeutic drugs for specific cancers. Their inclusion not only reflects the country’s great emphasis on people’s lives and health, but also demonstrates the continuous improvement of my country’s medical security system. Through the coverage of medical insurance, we expect these two drugs to be more widely used in clinical practice and bring more hope for survival and treatment options to cancer patients.